search
Back to results

Comparison of Metoprolol and Tramadol With Remifentanil in Endoscopic Sinus Surgery

Primary Purpose

Nasal Polyps

Status
Completed
Phase
Phase 4
Locations
Turkey
Study Type
Interventional
Intervention
Remifentanil
Tramadol
Metoprolol
Sponsored by
Rize Üniversitesi
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Nasal Polyps focused on measuring Drug: remifentanil, Drug: tramadol, Drug: metoprolol, Functional endoscopic sinus surgery, Controlled hypotension

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • diagnosis of rhinosinusitis
  • indication for functional endoscopic sinus surgery

Exclusion Criteria:

  • American Society of Anesthesiologists risk score > 2
  • undertreated hypertension
  • Haemoglobin A1c test level > 7.5
  • pregnancy
  • concurrent surgery
  • history of drug abuse
  • history of or new diagnosis of allergy to any of the study drugs
  • history of post-operative nausea and vomiting

Sites / Locations

  • Recep Tayyip Erdogan University

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

remifentanil

tramadol + metoprolol

Arm Description

Following an intravenous bolus dose of 0.5 µg/kg remifentanil administered just before the induction of anaesthesia, patients will receive an intravenous infusion of remifentanil at a dose of 0.25-0.5 µg/kg/min throughout the surgery. The rate of infusion will be adjusted to maintain a mean blood pressure within %70-80 of the baseline value. At the end of the surgery, the rate of infusion will be decreased to 0.05 µg/kg/min, and continued until the patient is extubated.

Just before the induction of anaesthesia, an intravenous infusion of 1 mg/kg of tramadol in 100 ml isotonic fluid will be started. The infusion will be completed in 30 minutes using a perfusor. Additionally, following the administration of the neuromuscular blocking agent, 0.1 mg/kg of intravenous metoprolol will be administered within 5 minutes.

Outcomes

Primary Outcome Measures

Intraoperative Bleeding Score
Intraoperative bleeding score is reported by the surgeon according to Boezaart Surgical Field Grading scale. The scale ranges from 0 to 5. '0' is the best, and '5' is the worst outcome. The scale construct is: 0 No bleeding. Slight bleeding, no suction is required. Slight bleeding, occasional suctioning required. Slight bleeding, frequent suctioning required. Bleeding threatens surgical field a few seconds after suction is removed. Moderate bleeding, frequent suctioning required. Bleeding threatens surgical field as soon as suction is removed. Severe bleeding, constant suctioning required. Bleeding appears faster than suctioning. Thoroughout the intraoperative period, the surgeon is free to report a score at any time he/she sees appropriate.

Secondary Outcome Measures

Time to Achieve Intraoperative Bleeding Score < 3
The intraoperative bleeding score will be reported by the surgeon throughout surgery. At the start of the surgery, a timer will be used to measure the duration to achieve a bleeding score of 2.
Bleeding Rate
In the end of each surgery, bleeding rate will be calculated as ml/min by dividing total bleeding (amount of blood in the graded suction and sponges minus total irrigation fluid) to the duration of surgery (excluding local anesthetic infiltration, and nasal packing).
Postoperative Pain
Postoperative pain scores on the day of surgery will be evaluated with a visual analog scale (0: no pain, 10: worst pain ever) at the post anaesthetic care unit (PACU), and the surgical ward. The evaluation will begin after the patient arrives at the post anaesthetic care unit, and will continue for 24 hours.
Number of Participants With Postoperative Nausea and Vomiting
Postoperative nausea, retching, and vomiting on the day of surgery will be evaluated with a four-point ordinal scale (0-none, 1-nausea, 2-retching, 3-vomiting) at the post anaesthetic care unit, and the surgical ward. The evaluation will begin after the patient arrives at the post anaesthetic care unit, and will continue for 24 hours.

Full Information

First Posted
June 19, 2015
Last Updated
September 9, 2019
Sponsor
Rize Üniversitesi
search

1. Study Identification

Unique Protocol Identification Number
NCT02484859
Brief Title
Comparison of Metoprolol and Tramadol With Remifentanil in Endoscopic Sinus Surgery
Official Title
Comparison of Normotensive Anesthesia Using a Combination of Metoprolol and Tramadol With Controlled Hypotension Using Remifentanil in Endoscopic Sinus Surgery
Study Type
Interventional

2. Study Status

Record Verification Date
September 2019
Overall Recruitment Status
Completed
Study Start Date
July 2015 (undefined)
Primary Completion Date
December 2015 (Actual)
Study Completion Date
February 2016 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Rize Üniversitesi

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Functional endoscopic sinus surgery (FESS) is indicated in diseases such as chronic sinusitis refractory to medical treatment, nasal polyposis, mass lesions in the nasal cavity. The purpose of this study is to determine whether tramadol and metoprolol are as effective as remifentanil in providing controlled hypotension during FESS.
Detailed Description
This study aims to compare two techniques for controlled hypotension during FESS. In both cases, the patients will be evaluated during the preoperative anesthetic visit, and will be given care by an anesthesiologist during the perioperative period. Patients who are scheduled for an elective FESS operation will be included in the study. During the preoperative anaesthetic visit, patients who do not meet any of the the exclusion criteria will be offered to participate in hte study. Patients accepting to contribute tot he study will be randomised into one of the two groups via closed envelope technique. A pilot study with 20 patients resulted in similar means and slightly different standard deviations of mean blood pressure. This pilot study showed that 44 patients in each group are sufficient to obtain 80% power with an alpha error of 0.05 and beta error of 20%. To compensate for missing/inconsistent data, or allow for better matching of the demographic variables, 3-5 additional patients will be recruited. The anesthesiologist in charge of the patient will not be blinded to the groups, and will be responsible for maintaining the hypotension (and patient safety) with either remifentanil in one group, or tramadol and metoprolol in the other group. Systolic, diastolic, and mean blood pressures, and heart rate will be recorded into a spreadsheet every three minutes during the anaesthetic and surgical period. The data will be recorded via an excel form, which will validate the entries upon entrance. The accuracy and completeness of registry data will be verified by a third investigator, who will compare the registry data to the medical monitor records at the end of each operative day. The surgeon will be blinded to the groups, and will be responsible for scoring the surgical vision and bleeding with the intraoperative bleeding score. The study drugs will be administered via the same type of infusion pump to facilitate the blinding process. Any adverse event will be reported in the patient chart and study records. Statistical analysis will be carried out using R and Statistical Package for the Social Sciences (SPSS) programs. Demographic variables (age, gender, American Society of Anesthesiologists (ASA) score, comorbidities) will be analysed using descriptive statistics. Study variables such as duration of operation, variance of the hemodynamic parameters, amount of bleeding, bleeding score, occurrence of adverse events will be analysed with the appropriate statistical tests.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Nasal Polyps
Keywords
Drug: remifentanil, Drug: tramadol, Drug: metoprolol, Functional endoscopic sinus surgery, Controlled hypotension

7. Study Design

Primary Purpose
Other
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
88 (Actual)

8. Arms, Groups, and Interventions

Arm Title
remifentanil
Arm Type
Active Comparator
Arm Description
Following an intravenous bolus dose of 0.5 µg/kg remifentanil administered just before the induction of anaesthesia, patients will receive an intravenous infusion of remifentanil at a dose of 0.25-0.5 µg/kg/min throughout the surgery. The rate of infusion will be adjusted to maintain a mean blood pressure within %70-80 of the baseline value. At the end of the surgery, the rate of infusion will be decreased to 0.05 µg/kg/min, and continued until the patient is extubated.
Arm Title
tramadol + metoprolol
Arm Type
Active Comparator
Arm Description
Just before the induction of anaesthesia, an intravenous infusion of 1 mg/kg of tramadol in 100 ml isotonic fluid will be started. The infusion will be completed in 30 minutes using a perfusor. Additionally, following the administration of the neuromuscular blocking agent, 0.1 mg/kg of intravenous metoprolol will be administered within 5 minutes.
Intervention Type
Drug
Intervention Name(s)
Remifentanil
Other Intervention Name(s)
Ultiva
Intervention Description
Remifentanil infusion will be started with a bolus dose of 0.5 µg/kg before the induction, and will be continued throughout the surgery at a dose of 0.25-0.5 µg/kg/min. At the end of the surgery, the rate of infusion will be decreased to 0.05 µg/kg/min, and continued until the patient is extubated.
Intervention Type
Drug
Intervention Name(s)
Tramadol
Other Intervention Name(s)
Contramal
Intervention Description
1 mg/kg tramadol will be added to 100 ml of isotonic fluid, and will be administered intravenously in exactly 30 minutes via a perfusor. The infusion will be started just before the induction.
Intervention Type
Drug
Intervention Name(s)
Metoprolol
Other Intervention Name(s)
Beloc
Intervention Description
0.1 mg/kg of metoprolol will be administered intravenously within 5 minutes following the administration of neuromuscular blocking agent.
Primary Outcome Measure Information:
Title
Intraoperative Bleeding Score
Description
Intraoperative bleeding score is reported by the surgeon according to Boezaart Surgical Field Grading scale. The scale ranges from 0 to 5. '0' is the best, and '5' is the worst outcome. The scale construct is: 0 No bleeding. Slight bleeding, no suction is required. Slight bleeding, occasional suctioning required. Slight bleeding, frequent suctioning required. Bleeding threatens surgical field a few seconds after suction is removed. Moderate bleeding, frequent suctioning required. Bleeding threatens surgical field as soon as suction is removed. Severe bleeding, constant suctioning required. Bleeding appears faster than suctioning. Thoroughout the intraoperative period, the surgeon is free to report a score at any time he/she sees appropriate.
Time Frame
throughout surgery, up to 3 hours
Secondary Outcome Measure Information:
Title
Time to Achieve Intraoperative Bleeding Score < 3
Description
The intraoperative bleeding score will be reported by the surgeon throughout surgery. At the start of the surgery, a timer will be used to measure the duration to achieve a bleeding score of 2.
Time Frame
throughout surgery, up to 20 minutes
Title
Bleeding Rate
Description
In the end of each surgery, bleeding rate will be calculated as ml/min by dividing total bleeding (amount of blood in the graded suction and sponges minus total irrigation fluid) to the duration of surgery (excluding local anesthetic infiltration, and nasal packing).
Time Frame
throughout surgery, up to 3 hours
Title
Postoperative Pain
Description
Postoperative pain scores on the day of surgery will be evaluated with a visual analog scale (0: no pain, 10: worst pain ever) at the post anaesthetic care unit (PACU), and the surgical ward. The evaluation will begin after the patient arrives at the post anaesthetic care unit, and will continue for 24 hours.
Time Frame
following extubation, up to 24 hours
Title
Number of Participants With Postoperative Nausea and Vomiting
Description
Postoperative nausea, retching, and vomiting on the day of surgery will be evaluated with a four-point ordinal scale (0-none, 1-nausea, 2-retching, 3-vomiting) at the post anaesthetic care unit, and the surgical ward. The evaluation will begin after the patient arrives at the post anaesthetic care unit, and will continue for 24 hours.
Time Frame
following extubation, up to 24 hours

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: diagnosis of rhinosinusitis indication for functional endoscopic sinus surgery Exclusion Criteria: American Society of Anesthesiologists risk score > 2 undertreated hypertension Haemoglobin A1c test level > 7.5 pregnancy concurrent surgery history of drug abuse history of or new diagnosis of allergy to any of the study drugs history of post-operative nausea and vomiting
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Başar Erdivanlı, Asst. Prof.
Organizational Affiliation
Recep Tayyip Erdogan University, Medical Faculty, Department of Anesthesiology
Official's Role
Principal Investigator
Facility Information:
Facility Name
Recep Tayyip Erdogan University
City
Rize
State/Province
Eastern Blacksea
ZIP/Postal Code
53100
Country
Turkey

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
We are still evaluating the guideline of the Medical Research Council (MRC) Hubs for Trials Methodology Research (HTMR) for individual participant data sharing.
Citations:
PubMed Identifier
24403974
Citation
Hosemann W, Draf C. Danger points, complications and medico-legal aspects in endoscopic sinus surgery. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2013 Dec 13;12:Doc06. doi: 10.3205/cto000098.
Results Reference
background
PubMed Identifier
21467830
Citation
Cincikas D, Ivaskevicius J, Martinkenas JL, Balseris S. A role of anesthesiologist in reducing surgical bleeding in endoscopic sinus surgery. Medicina (Kaunas). 2010;46(11):730-4.
Results Reference
background
PubMed Identifier
19128632
Citation
Lin D, Dalgorf D, Witterick IJ. Predictors of unexpected hospital admissions after outpatient endoscopic sinus surgery: retrospective review. J Otolaryngol Head Neck Surg. 2008 Jun;37(3):309-11.
Results Reference
background
PubMed Identifier
17991265
Citation
Komatsu R, Turan AM, Orhan-Sungur M, McGuire J, Radke OC, Apfel CC. Remifentanil for general anaesthesia: a systematic review. Anaesthesia. 2007 Dec;62(12):1266-80. doi: 10.1111/j.1365-2044.2007.05221.x.
Results Reference
background
PubMed Identifier
16444651
Citation
Rathjen T, Bockmuhl U, Greim CA. [Modern anesthesiologic concepts supporting paranasal sinus surgery]. Laryngorhinootologie. 2006 Jan;85(1):20-3. doi: 10.1055/s-2005-870562. German.
Results Reference
background
PubMed Identifier
16856048
Citation
Khalil HS, Nunez DA. Functional endoscopic sinus surgery for chronic rhinosinusitis. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004458. doi: 10.1002/14651858.CD004458.pub2.
Results Reference
background
PubMed Identifier
15816598
Citation
Sartcaoglu F, Celiker V, Basgul E, Yapakci O, Aypar U. The effect of hypotensive anaesthesia on cognitive functions and recovery at endoscopic sinus surgery. Eur J Anaesthesiol. 2005 Feb;22(2):157-9. doi: 10.1017/s0265021505230284. No abstract available.
Results Reference
background

Learn more about this trial

Comparison of Metoprolol and Tramadol With Remifentanil in Endoscopic Sinus Surgery

We'll reach out to this number within 24 hrs